Mulders PF - Search Results

1

Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience.

Patard JJ, Leray E, Rioux-Leclercq N, Cindolo L, Ficarra V, Zisman A, De La Taille A, Tostain J, Artibani W, Abbou CC, Lobel B, Guillé F, Chopin DK, Mulders PF, Wood CG, Swanson DA, Figlin RA, Belldegrun AS, Pantuck AJ. Patard JJ, et al. Among authors: mulders pf. J Clin Oncol. 2005 Apr 20;23(12):2763-71. doi: 10.1200/JCO.2005.07.055. J Clin Oncol. 2005. PMID: 15837991

2

Tumor heterogeneity as prognostic factor in patients with low-stage (T1-3N0M0) renal-cell carcinoma.

van der Poel HG, Mulders PF, Oosterhof GO, Schaafsma HE, Hendriks JC, Schalken JA, Debruyne FM. van der Poel HG, et al. Among authors: mulders pf. Investig Urol (Berl). 1994;5:60-5. Investig Urol (Berl). 1994. PMID: 7719322 No abstract available.

3

Prognostic value of karyometric and clinical characteristics in renal cell carcinoma. Quantitative assessment of tumor heterogeneity.

van der Poel HG, Mulders PF, Oosterhof GO, Schaafsma HE, Hendriks JC, Schalken JA, Debruyne FM. van der Poel HG, et al. Among authors: mulders pf. Cancer. 1993 Nov 1;72(9):2667-74. doi: 10.1002/1097-0142(19931101)72:9<2667::aid-cncr2820720924>3.0.co;2-0. Cancer. 1993. PMID: 8402488

4

The role of adjuvant immunotherapy in renal cell carcinoma.

Mulders PF, De Mulder PH. Mulders PF, et al. Curr Urol Rep. 2002 Feb;3(1):44-9. doi: 10.1007/s11934-002-0010-y. Curr Urol Rep. 2002. PMID: 12084219 Review.

5

Immunotherapy for renal cell carcinoma.

Bleumer I, Oosterwijk E, De Mulder P, Mulders PF. Bleumer I, et al. Among authors: mulders pf. Eur Urol. 2003 Jul;44(1):65-75. doi: 10.1016/s0302-2838(03)00191-x. Eur Urol. 2003. PMID: 12814677 Review.

6

Targeting of adenovirus to human renal cell carcinoma cells.

Jongmans W, van den Oudenalder K, Tiemessen DM, Molkenboer J, Willemsen R, Mulders PF, Oosterwijk E. Jongmans W, et al. Among authors: mulders pf. Urology. 2003 Sep;62(3):559-65. doi: 10.1016/s0090-4295(03)00378-9. Urology. 2003. PMID: 12946777

7

Tumor antigens and markers in renal cell carcinoma.

Mulders P, Bleumer I, Oosterwijk E. Mulders P, et al. Urol Clin North Am. 2003 Aug;30(3):455-65. doi: 10.1016/s0094-0143(03)00024-7. Urol Clin North Am. 2003. PMID: 12953748 Review.

8

A pilot trial of tumor lysate-loaded dendritic cells for the treatment of metastatic renal cell carcinoma.

Gitlitz BJ, Belldegrun AS, Zisman A, Chao DH, Pantuck AJ, Hinkel A, Mulders P, Moldawer N, Tso CL, Figlin RA. Gitlitz BJ, et al. J Immunother. 2003 Sep-Oct;26(5):412-9. doi: 10.1097/00002371-200309000-00004. J Immunother. 2003. PMID: 12973030 Clinical Trial.

9

Validation of an integrated staging system toward improved prognostication of patients with localized renal cell carcinoma in an international population.

Han KR, Bleumer I, Pantuck AJ, Kim HL, Dorey FJ, Janzen NK, Zisman A, Dinney CP, Wood CG, Swanson DA, Said JW, Figlin RA, Mulders PF, Belldegrun AS. Han KR, et al. Among authors: mulders pf. J Urol. 2003 Dec;170(6 Pt 1):2221-4. doi: 10.1097/01.ju.0000096049.64863.a1. J Urol. 2003. PMID: 14634383

10

Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience.

Patard JJ, Shvarts O, Lam JS, Pantuck AJ, Kim HL, Ficarra V, Cindolo L, Han KR, De La Taille A, Tostain J, Artibani W, Abbou CC, Lobel B, Chopin DK, Figlin RA, Mulders PF, Belldegrun AS. Patard JJ, et al. Among authors: mulders pf. J Urol. 2004 Jun;171(6 Pt 1):2181-5, quiz 2435. doi: 10.1097/01.ju.0000124846.37299.5e. J Urol. 2004. PMID: 15126781

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

251 results

Search Page

Filters